QuickView for positive regulation of G2/MI transition of meiotic cell cycle (biogroup)

1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
2. Myeloid-derived suppressor splenocytes from mice with or without esophageal tumors
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
5. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens

There were no matches for positive regulation of G2/MI transition of meiotic cell cycle

There were no clinical trials for positive regulation of G2/MI transition of meiotic cell cycle